Kanzaki, Masato
Takagi, Ryo
Washio, Kaoru
Kokubo, Mami
Yamato, Masayuki
Article History
Received: 3 March 2017
Revised: 23 August 2017
Accepted: 31 August 2017
First Online: 11 October 2017
Competing interests
: Dr. Masayuki Yamato has equity financial interest in CellSeed, Tokyo, Japan, a publicly traded Japanese biotechnology company exclusively developing cell sheet technology for regenerative medicine purposes. All the other authors declare that they have no competing financial interests.